Advertisement

Topics

Oncternal starts CIRLL study of cirmtuzumab and ibrutinib

19:00 EDT 16 May 2018 | Net Resources International

Oncternal Therapeutics has started the CIRLL study, a Phase Ib/II clinical trial of cirmtuzumab and ibrutinib combination for the treatment...
Read More...

The post Oncternal starts CIRLL study of cirmtuzumab and ibrutinib appeared first on Drug Development Technology.

Original Article: Oncternal starts CIRLL study of cirmtuzumab and ibrutinib

NEXT ARTICLE

More From BioPortfolio on "Oncternal starts CIRLL study of cirmtuzumab and ibrutinib"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...